首页 › 基金 › Crocodile Capital Partners GmbH › BNTX
Crocodile Capital Partners GmbH 对 BNTX 的持仓历史
BIONTECH SE · 医疗保健
Crocodile Capital Partners GmbH 在 Q3 2026 的 13F 申报中披露持有 BNTX(BIONTECH SE)17,423 股,市值约 US$1.7M,约占其申报组合的 1.07%,在其申报持仓中市值排名第 7 位。 Crocodile Capital Partners GmbH 最近 13 个申报季度中有 13 个季度披露了 BNTX 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-09 · 来源: SEC EDGAR Form 13F-HR
Crocodile Capital Partners GmbH 对 BNTX 的持仓演变
Crocodile Capital Partners GmbH 于 Q3 2023 首次披露 BNTX 持仓:29,586 股(约 US$3.2M)。 该持仓在 Q3 2024 达到峰值 29,586 股,市值约 US$3.5M。 在 13 次申报中,Crocodile Capital Partners GmbH 0 次增持、1 次减持、11 次保持不变。 最近一期申报(Q3 2026)显示持股 17,423 股、市值约 US$1.7M,环比减持 -12,163 股。。 持仓曾出现大幅变动:Q3 2026 减持约 41% (随后一个季度股价下跌 10%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 29.59K | $3.21M | 新进 |
| Q4 2023 | 29.59K | $3.12M | 持有 |
| Q1 2024 | 29.59K | $2.73M | 持有 |
| Q2 2024 | 29.59K | $2.38M | 持有 |
| Q3 2024 | 29.59K | $3.51M | 持有 |
| Q4 2024 | 29.59K | $3.37M | 持有 |
| Q1 2025 | 29.59K | $2.69M | 持有 |
| Q2 2025 | 29.59K | $3.15M | 持有 |
| Q3 2025 | 29.59K | $2.92M | 持有 |
| Q4 2025 | 29.59K | $2.82M | 持有 |
| Q1 2026 | 29.59K | $2.82M | 持有 |
| Q2 2026 | 29.59K | $2.75M | 持有 |
| Q3 2026 | 17.42K | $1.71M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 BNTX 与 13F 数据
BNTX(BIONTECH SE)属于医疗保健行业。我们追踪的基金中还有 35 只申报持有 BNTX,申报仓位最大的包括:FLOSSBACH VON STORCH SE (US$207.1M), Temasek Holdings (Private) Ltd (US$140.1M), Logos Global Management LP (US$94.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BNTX 的基金
- FLOSSBACH VON STORCH SE 2.23M 股 · $207.14M · Q2 2026
- Temasek Holdings (Private) Ltd 1.51M 股 · $140.14M · Q2 2026
- Logos Global Management LP 1.01M 股 · $94.45M · Q2 2026
- GSK plc 889.82K 股 · $82.80M · Q2 2026
- Davern Capital Partners, LP 754.55K 股 · $70.21M · Q2 2026
- Long Focus Capital Management, LLC 624.00K 股 · $58.06M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 470.00K 股 · $43.73M · Q2 2026
更多关于 Crocodile Capital Partners GmbH
常见问题
How long has Crocodile Capital Partners GmbH held BNTX?
Crocodile Capital Partners GmbH has disclosed BNTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Crocodile Capital Partners GmbH's current position in BNTX?
As of Q3 2026, Crocodile Capital Partners GmbH holds 17.42K shares of BNTX (BIONTECH SE), valued at $1.71M, representing 1.07% of its reported portfolio and ranking #7.
Has Crocodile Capital Partners GmbH been buying or selling BNTX?
In the latest 13F filing (Q3 2026), Crocodile Capital Partners GmbH reduced its position in BNTX. The position peaked in Q3 2024 at 29.59K shares.
Which other funds hold BNTX?
Other major institutional holders of BNTX include FLOSSBACH VON STORCH SE, Temasek Holdings (Private) Ltd, Logos Global Management LP, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.